Jump to content

Drilldown: Medicines

Choose a table:


Medicines > classes: 5HT2A/D2 antagonist with proposed differential pre/post-synaptic D2 activity & routes: Oral

Use the filters below to narrow your results.

generic:
None (1)
brand:
Caplyta (1)
classes: (Click arrow to add another value)
mechanism:
None (1)
uses:
Schizophrenia (FDA-approved Dec 2019). Bipolar depression as monotherapy or adjunct to lithium/valproate (FDA-approved Dec 2021). (1)
starting dose:
42 mg PO once daily with food (no titration) (1)
preparations:
42 mg capsules (1)
fda max:
42 mg/d (1)
routes: (Click arrow to add another value)
onset:
Antipsychotic effect over weeks (1)
duration:
Daily dosing (1)
halflife:
~18 hours (terminal) (1)
bioavailability:
Limited but adequate; take with food (1)
pregnancy:
Limited data; National Pregnancy Registry for Atypical Antipsychotics (1)
legal:
Rx (1)

Showing below up to 1 result in range #1 to #1.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"